To the Editor: Liver injury has been observed in patients with COVID-19, at an incidence ranging from 14-53%.[[1]] We examined the liver injury patterns and implication of non-alcoholic fatty liver diseases (NAFLD) on clinical outcomes in Chinese patients with COVID-19. Methods From January 20 through February 17, 2020, consecutive patients admitted to 2 designated COVID-19 Hospitals in China with confirmed COVID-19 and information on NAFLD status were studied. Discussion Similar to other reports, our study showed that liver injury in patients with COVID-19 was frequent but mild in nature.[[1]] The pattern of liver injury was mostly hepatocellular rather than cholestatic. [Extracted from the article]